Natco Pharma announces 2:21 rights issue at ₹750 per share

Natco Pharma announces 2:21 rights issue at ₹750 per share. The rights issue allows shareholders to subscribe to 2 new shares for every 21 held at an issue price of ₹750 per share, including a premium of ₹748. The move aims to strengthen the company's capital structure and fund future growth initiatives. The rights will be issued in the proportion of 2:21 based on existing shareholding.

📊 STOCKS: $NATCOPHARM | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #RightsIssue